Avacta Group (AVCT) News Today GBX 48.47 +4.22 (+9.54%) (As of 08:23 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Avacta Group (LON:AVCT) Stock Price Up 11.2% - What's Next?Avacta Group (LON:AVCT) Trading Up 11.2% - Should You Buy?November 21 at 5:58 AM | marketbeat.comInvestors in Avacta Group (LON:AVCT) have seen splendid returns of 163% over the past five yearsNovember 13, 2024 | finance.yahoo.comAvacta Group (LON:AVCT) Stock Price Crosses Below Two Hundred Day Moving Average - Here's What HappenedAvacta Group (LON:AVCT) Stock Price Crosses Below 200 Day Moving Average - Here's What HappenedNovember 5, 2024 | marketbeat.comAvacta Group (LON:AVCT) Share Price Crosses Above 200 Day Moving Average - What's Next?Avacta Group (LON:AVCT) Stock Price Passes Above 200-Day Moving Average - Here's WhyOctober 26, 2024 | marketbeat.comAvacta Group (LON:AVCT) Share Price Passes Above 200-Day Moving Average - Time to Sell?Avacta Group (LON:AVCT) Stock Price Passes Above 200 Day Moving Average - What's Next?October 18, 2024 | marketbeat.comAvacta Group (LON:AVCT) Stock Price Up 7.2% - What's Next?Avacta Group (LON:AVCT) Shares Up 7.2% - What's Next?October 10, 2024 | marketbeat.comAvacta Group Share Chat (AVCT)October 3, 2024 | lse.co.ukAvacta Group First Half 2024 Earnings: UK£0.038 loss per share (vs UK£0.043 loss in 1H 2023)October 3, 2024 | uk.finance.yahoo.comAvacta Group (LON:AVCT) Stock Price Up 8.4%Avacta Group (LON:AVCT) Stock Price Up 8.4%October 3, 2024 | marketbeat.comAvacta Group (LON:AVCT) Share Price Crosses Above Two Hundred Day Moving Average of $56.59Avacta Group (LON:AVCT) Share Price Passes Above 200 Day Moving Average of $56.59September 25, 2024 | marketbeat.comAvacta Group (LON:AVCT) Shares Pass Above 200-Day Moving Average of $56.62Avacta Group (LON:AVCT) Shares Pass Above Two Hundred Day Moving Average of $56.62September 11, 2024 | marketbeat.comAvacta Group Plc (LON:AVCT) Insider Tony Peter Gardiner Sells 500,000 SharesSeptember 4, 2024 | insidertrades.comAvacta Group (LON:AVCT) Stock Price Crosses Above Two Hundred Day Moving Average of $58.99Avacta Group (LON:AVCT) Shares Cross Above 200 Day Moving Average of $58.99August 24, 2024 | marketbeat.comAvacta Group Plc (AVCTF)July 27, 2024 | uk.finance.yahoo.comAvacta Group Plc reports FY resultsMay 1, 2024 | msn.comAvacta Group (LON:AVCT) investors are sitting on a loss of 82% if they invested three years agoMay 1, 2024 | finance.yahoo.comUpdated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024March 6, 2024 | finance.yahoo.comAvacta Group: Appointment of Chief Business OfficerDecember 19, 2023 | finanznachrichten.deAppointment of Chief Business OfficerDecember 19, 2023 | finance.yahoo.comALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study DataDecember 13, 2023 | finance.yahoo.comAnixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory BoardOctober 23, 2023 | finance.yahoo.comIf I’d invested £1,000 in Avacta shares 5 years ago, here’s how much I’d have nowSeptember 11, 2023 | msn.comAvacta Group Share ChatAugust 11, 2023 | lse.co.ukAvacta Completes Fifth Dose Escalation in AVA6000 Phase 1 Clinical StudyJune 21, 2023 | marketwatch.comAvacta Group plc: Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical StudyJune 21, 2023 | finanznachrichten.deAvacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical StudyJune 21, 2023 | finance.yahoo.comAvacta Group Says No Fundraising Imminent; Shares RiseJune 19, 2023 | marketwatch.comAVCT.L - Avacta Group PlcJune 6, 2023 | uk.finance.yahoo.comFirst Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical StudyApril 27, 2023 | finance.yahoo.comAvacta Group plc: Avacta Announces First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation StudyApril 5, 2023 | finanznachrichten.deAvacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics DivisionMarch 28, 2023 | finance.yahoo.comIs the Avacta share price dip a buying opportunity?March 16, 2023 | msn.comBlock Listing Application to AIMJanuary 17, 2023 | lse.co.ukAvacta Group Plc (LON:AVCT) is favoured by institutional owners who hold 58% of the companyOctober 21, 2022 | finance.yahoo.comAvacta Group Plc (AVCT.L)October 1, 2022 | uk.finance.yahoo.comAvacta's AVA6000 Gets FDA Orphan Drug Designation To Treat Soft Tissue Sarcoma; Stock UpSeptember 5, 2022 | nasdaq.comLG Chem Renews License Triggering Payment to AvactaJune 30, 2022 | finance.yahoo.comAffyXell Expands its Strategic Partnership With...May 16, 2022 | benzinga.comAvacta full-year results push shares higherApril 6, 2022 | proactiveinvestors.comIs Avacta Group (LON:AVCT) In A Good Position To Invest In Growth?March 19, 2022 | finance.yahoo.comWhat’s next for the Avacta share price?March 17, 2022 | uk.finance.yahoo.comThe Avacta share price: buy or avoid like the plague?March 1, 2022 | uk.news.yahoo.comAvacta Group selects second pre|CISION drug candidate for developmentJanuary 18, 2022 | msn.comAvacta Selects Second pre|CISION™ Pro-drug Candidate for DevelopmentJanuary 18, 2022 | finance.yahoo.comAvacta pauses sales of COVID-19 antigen test to improve Omicron sensitivityJanuary 10, 2022 | reuters.comUK Stocks Factors to watch on Jan. 10January 10, 2022 | reuters.comAvacta pauses sales of COVID-19 antigen test to boost Omicron sensitivityJanuary 10, 2022 | msn.comAvacta Group PLC : Change of auditorDecember 16, 2021 | markets.businessinsider.comWhat’s going on with the Avacta share price?December 15, 2021 | fool.co.ukAvacta Group plc: Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000November 29, 2021 | finanznachrichten.de Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late. Click here to watch it now. AVCT Media Mentions By Week AVCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVCT News Sentiment▼1.170.46▲Average Medical News Sentiment AVCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVCT Articles This Week▼10▲AVCT Articles Average Week Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Oxford Biomedica News PureTech Health News Bioventix News Arix Bioscience News hVIVO News Faron Pharmaceuticals Oy News Scancell News Futura Medical News Redx Pharma News e-therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AVCT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVCT Stock Alerts